Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01537237 · ClinicalTrials.gov registry record
Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation
A clinical trial of Atrial Fibrillation and Arrhythmia, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- 37
- Enrollment target
- 2
- Study locations
NCT01537237 is a study of Atrial Fibrillation and Arrhythmia that has completed, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 37 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01537237, a study of Atrial Fibrillation and Arrhythmia, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare rotational angiography (3DATG technology)intra-procedure (during the ablation procedure) with CT (x-ray) pre-procedure (before the ablation procedure) fusion to create an anatomical picture of a heart to help adequately guide an ablation procedure for patients with arrhythmias.
Conditions Studied
Study Locations (2)
Florida
- Holy Cross Hospital - Fort Lauderdale
Massachusetts
- St. Elizabeth's Medical Center - Brighton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01537237
The ClinicalTrials.gov registry entry for NCT01537237 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The listed sponsor is Steward St. Elizabeth's Medical Center of Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT01537237 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01537237 about?
NCT01537237 is a clinical study titled "Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation". The purpose of this study is to compare rotational angiography (3DATG technology)intra-procedure (during the ablation procedure) with CT (x-ray) pre-procedure (before the ablation procedure) fusion to create an anatomical picture of a heart to help adequately guide an ablation procedure for patients...
What is the current status of trial NCT01537237?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2011-08. Estimated completion is 2014-11.
What conditions does trial NCT01537237 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Arrhythmia.
Who is sponsoring clinical trial NCT01537237?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01537237 being conducted?
This trial has 2 study locations across Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.